1. Home >
  2. Companies >
  3. Public >
  4. Life Science >
  5. United States >
  6. California >
  7. iBio >
  8. M&A

iBio Mergers & Acquisitions

iBio M&A Summary

iBio has acquired 1 company, including 1 in the last 5 years. It has also divested 1 asset.

It’s largest disclosed sale occurred in 2024, when it sold iBio - Preclinical PD-1 Agonist Antibody Program to Otsuka Pharmaceutical Co. for $53M. iBio has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity1
    • M&A Sell Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1

iBio

iBio, Inc.

11750 Sorrento Valley Road, Suite 200,
San Diego, California 92121
United States,
(979) 446-0027
www.ibioinc.com

All (2) Buy (1) Sell (1)
Date Target Value
$mlns 		Transaction Type Acquirer Seller SRC
Link
2024-02-25 iBio - Preclinical PD-1 Agonist Antibody Program · Life Science
Bryan, Texas

iBio - Preclinical PD-1 Agonist Antibody Program is a pivotal checkpoint in the immune system, acting as a type of off switch that helps keep the cells from attacking other cells in the body. iBio's Preclinical PD-1 Agonist Antibody Program is based in Bryan, Texas.

53 Divestiture

Otsuka

iBio


Try Mergr Free — See This and 221,316+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Try Free

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 215K M&A Transactions
  • 217K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Mergr

Solution for

Product

Company

Legal